Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Radiology

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1148/RADIOL.2451070353PMID 17704357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contrast Media: Safety Issues and ESUR Guidelines

  2009cited by this paper
• Nephrogenic Systemic Fibrosis: A Review of 6 Cases Temporally Related to Gadodiamide Injection (Omniscan)

  2007cited by this paper
• Gadolinium deposition in nephrogenic fibrosing dermopathy.

  2007cited by this paper
• Nephrogenic systemic fibrosis: risk factors and incidence estimation.

  2007cited by this paper
• Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.

  2007cited by this paper
• Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis.

  2007cited by this paper
• Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned.

  2007cited by this paper
• Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure.

  2006cited by this paper
• Nephrogenic Systemic Fibrosis Among Liver Transplant Recipients: A Single Institution Experience and Topic Update

  2006cited by this paper
• Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.

  2006cited by this paper
• Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

  2006cited by this paper
• Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

  2006cited by this paper
• Nephrogenic systemic fibrosis: an emerging threat among renal patients.

  2006cited by this paper
• Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

  2006cited by this paper
• Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide

  2006cited by this paper
• Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy.

  2005cited by this paper
• Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis

  2005cited by this paper
• Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review.

  2005cited by this paper
• Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin.

  2004cited by this paper
• Nephrogenic Fibrosing Dermopathy Treated with Extracorporeal Photopheresis

  2004cited by this paper
• UV-A1 phototherapy improves nephrogenic fibrosing dermopathy.

  2004cited by this paper
• Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases.

  2003cited by this paper
• Nephrogenic fibrosing dermopathy: the first 6 years

  2003cited by this paper
• Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure.

  2003cited by this paper
• Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease).

  2003cited by this paper
• Scleromyxoedema‐like changes in four renal dialysis patients

  2003cited by this paper
• Nephrogenic fibrosing dermopathy: suspect identified, motive unclear.

  2003cited by this paper
• Nephrogenic fibrosing dermopathy with systemic involvement.

  2003cited by this paper
• Scleromyxoedema-like cutaneous diseases in renal-dialysis patients.

  2000cited by this paper
• Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis.

  1998cited by this paper
• A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent.

  1991cited by this paper

• Guidelines and Controversies of Computed Tomography and Magnetic Resonance Imaging Contrast Media.

  2025cites this paper
• Gadolinium toxicity: mechanisms, clinical manifestations, and nanoparticle role

  2025influential citation
• Partial volume correction for quantifying venous oxygen saturation levels using contrast-enhanced MRI

  2025cites this paper
• The safety of magnetic resonance imaging contrast agents

  2024cites this paper
• Longitudinal Vascular Monitoring of Acute and Diabetic Kidney Diseases with 3D Renal Ultrafast Ultrasound Doppler Imaging

  2024cites this paper
• Predictive Model Based on Texture Analysis of Noncontrast Cardiac Magnetic Resonance Images for the Prognostic Evaluation of Cardiac Amyloidosis

  2024cites this paper
• Два брати – дві хвороби (гіпертрофійна кардіоміопатія і амілоїдоз серця): причини різні чи одна й та ж (огляд літератури, опис клінічних випадків)

  2024cites this paper
• Polymeric Metal Contrast Agents for T1-Weighted Magnetic Resonance Imaging of the Brain.

  2023cites this paper
• Development of a Suite of Gadolinium-Free OATP1-Targeted Paramagnetic Probes for Liver MRI.

  2023cites this paper
• Development of a highly efficient gadolinium(III) potentiometric sensor using two aza-crown ether-based multiple diglycolamides (DGAs)

  2023cites this paper
• Radiomics applications in cardiac imaging: a comprehensive review

  2023cites this paper
• Identification of Myocardial Scarring Using Contrast‐Free Cardiac MRI in Patients With Autoimmune Rheumatic Diseases

  2023cites this paper
• Determination of Relative Weightings for Sacroiliac Joint Pathologies in the OMERACT Juvenile Arthritis Magnetic Resonance Imaging Sacroiliac Joint Score

  2023cites this paper
• Diagnosis of Acute Myocarditis Using Texture-Based Cardiac Magnetic Resonance, with CINE Imaging as a Novel Tissue Characterization Technique

  2022cites this paper
• Differentiating between cardiac amyloidosis and hypertrophic cardiomyopathy on non-contrast cine-magnetic resonance images using machine learning-based radiomics

  2022cites this paper
• Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration

  2022cites this paper
• Non-Contrast T2-Weighted MR Sequences for Long Term Monitoring of Asymptomatic Convexity Meningiomas

  2022cites this paper
• Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients

  2022cites this paper
• Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In Training.

  2021cites this paper
• Safety issues related to intravenous contrast agent use in magnetic resonance imaging

  2021cites this paper
• Preoperative evaluation of iliac blood vessels for first kidney transplant recipients: Combination of conventional and contrast-enhanced ultrasonography

  2021cites this paper
• Nanotechnology, Nanomedicine, and the Kidney

  2021cites this paper
• Overlapping roles of NADPH Oxidase 4 (Nox4) for diabetic and gadolinium-based contrast agent-induced systemic fibrosis.

  2021cites this paper
• Chronic Kidney Disease and Cerebrovascular Disease

  2021cites this paper
• Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal

  2021cites this paper
• Nephrogenic systemic fibrosis: A frivolous entity

  2021cites this paper
• Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective.

  2020cites this paper
• Use of Ferumoxytol enhanced Magnetic Resonance Angiography for cardiovascular assessment in late-stage chronic kidney disease

  2020cites this paper
• Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution.

  2020cites this paper
• Ultracompact Iron Oxide Nanoparticles with a Monolayer Coating of Succinylated Heparin: A New Class of Renal-Clearable and Nontoxic T1 Agents for High-Field MRI.

  2020cites this paper
• Impact of multimorbidity on risk and outcome of stroke: Lessons from chronic kidney disease

  2020cites this paper
• Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis.

  2020cites this paper
• Učestalost i raspodjela kalcificiranosti ilijačnih arterija u pacijenata u kojih je učinjena transplantacija bubrega

  2020cites this paper
• Nasopharyngeal carcinoma perfusion MRI

  2020cites this paper
• Combination of diffusion-weighted imaging and arterial spin labeling at 3.0 T for the clinical staging of nasopharyngeal carcinoma.

  2020cites this paper
• Nephrogenic Systemic Fibrosis: A Review of History, Pathophysiology, and Current Guidelines

  2019cites this paper
• Investigation Of Reducing Omniscan Toxicity Using Intracellular And Targeted N-Acetylcysteine Lysine Complex

  2019cites this paper
• A Secondary Analysis to Identify Patient-Centered Outcomes in the ACR's Appropriateness Criteria.

  2019cites this paper
• Microextraction of Gadolinium MRI contrast agent using core-shell Fe3O4@SiO2 nanoparticles: optimization of adsorption conditions and in-vitro study

  2019cites this paper
• Fibrotic Signaling Pathways of Skin Fibroblasts in Nephrogenic Systemic Fibrosis

  2019cites this paper
• Non-Contrast T2-Weighted MR Sequences for Long Term Monitoring of Asymptomatic Convexity Meningiomas.

  2019cites this paper
• Manganese‐Based Functional Nanoplatforms: Nanosynthetic Construction, Physiochemical Property, and Theranostic Applicability

  2019cites this paper
• Can amide proton transfer–weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?

  2019cites this paper
• The assessment of coronary artery disease in patients with end-stage renal disease

  2019cites this paper
• Influence of excess ligand on Nephrogenic Systemic Fibrosis associated with nonionic, linear gadolinium-based contrast agents.

  2019cites this paper
• A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis.

  2019cites this paper
• Is it time to relax nephrogenic systemic fibrosis guidelines and safely offer magnetic resonance imaging to more patients?

  2019cites this paper
• Gadoliniumablagerungen – Morbus Gadolinium

  2019cites this paper
• Letter on ‘European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis’

  2018cites this paper
• Construction of Hybrid Alginate Nanogels Loaded with Manganese Oxide Nanoparticles for Enhanced Tumor Magnetic Resonance Imaging.

  2018cites this paper
• Subacute and Chronic Left Ventricular Myocardial Scar: Accuracy of Texture Analysis on Nonenhanced Cine MR Images.

  2018cites this paper
• Do we need gadolinium-based contrast medium for brain magnetic resonance imaging in children?

  2018cites this paper
• Spectral Computed Tomography Angiography With a Gadolinium-based Contrast Agent: First Clinical Imaging Results in Cardiovascular Applications

  2018cites this paper
• Treatment of Acute Ischemic Stroke

  2018cites this paper
• Time‐of‐flight MR‐angiography with a helical trajectory and slice‐super‐resolution reconstruction

  2018cites this paper
• An Exploration into the Role of Diffusion Weighted MRI Imaging in the Assessment of Chronic Kidney Disease

  2018cites this paper
• Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR—a Systematic Review

  2018cites this paper
• Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.

  2018cites this paper
• Myocardial Viability Testing to Guide Coronary Revascularization.

  2018cites this paper
• Appropriate Minimal Dose of Gadobutrol for 3D Time-Resolved MRA of the Supra-Aortic Arteries: Comparison with Conventional Single-Phase High-Resolution 3D Contrast-Enhanced MRA

  2017cites this paper
• Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study

  2017cites this paper
• European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis

  2017cites this paper
• Neuroimaging in Pregnant Women

  2017cites this paper
• ACR Appropriateness Criteria® Pulsatile Abdominal Mass Suspected Abdominal Aortic Aneurysm.

  2017cites this paper
• Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients

  2017influential citation
• Pulsatile Abdominal Mass, Suspected Abdominal Aortic Aneurysm Variant

  2017cites this paper
• “Facial vascular anomalies; MRI and TRICKS-MR angiography diagnostic approach”

  2017cites this paper
• Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma

  2017cites this paper
• T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?

  2017cites this paper
• Retrospective Analysis of the Safety and Cost Implications of Pediatric Contrast-Enhanced Ultrasound at a Single Center.

  2017cites this paper
• Simultaneous detection of hepatocellular carcinoma and vessel thrombus by using SPIO-enhanced B-TFE with the T2 preparation pulse technique

  2017cites this paper
• What Happens to the Heart in Chronic Kidney Disease?

  2017cites this paper
• Gadolinium‐based contrast agents: A comprehensive risk assessment

  2017cites this paper
• MRI Applications: Classification According to Their Biodistribution

  2017cites this paper
• Reproducibility of Kidney Perfusion Measurements With Arterial Spin Labeling at 1.5 Tesla MRI Combined With Semiautomatic Segmentation for Differential Cortical and Medullary Assessment

  2016cites this paper
• Rare Earth Element Toxicity to Marine and Freshwater Algae

  2016cites this paper
• Renal function and diffusion-weighted imaging: a new method to diagnose kidney failure before losing half function

  2016cites this paper
• Gadolinium-Induced Fibrosis.

  2016cites this paper
• Pathophysiology of gadolinium-associated systemic fibrosis.

  2016cites this paper
• T 1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?

  2016cites this paper
• Magnetic Resonance Contrast Agents for Neuroradiology: Current Status

  2016cites this paper
• Gadolinium in Humans: A Family of Disorders.

  2016cites this paper
• Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.

  2016cites this paper
• Oxidative stress and its haemodynamic consequences in chronic kidney disease

  2016cites this paper
• Non-Contrast Renal Magnetic Resonance Imaging to Assess Perfusion and Corticomedullary Differentiation in Health and Chronic Kidney Disease

  2016cites this paper
• Imaging for Evaluation of Groin Pain

  2016cites this paper
• Нas the stability of gadoliniumbased magnetic resonance contrast media the clinical significance?

  2016cites this paper
• Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide

  2016cites this paper
• High-Performance Upconversion Nanoprobes for Multimodal MR Imaging of Acute Ischemic Stroke.

  2016cites this paper
• A Practical Guide to MR Imaging Safety: What Radiologists Need to Know.

  2015cites this paper
• Indicaciones y pruebas de imagen en la patología renal

  2015cites this paper
• Competitive extraction of Gd(III) into a carbon paste electrode impregnated with a nano-sized Gd(III)-imprinted polymer as a new method for its indirect voltammetric determination

  2015cites this paper
• Non-contrast-enhanced MR angiography for detecting arteriovenous fistula dysfunction in haemodialysis patients.

  2015cites this paper
• Half-dose gadoxetic acid-enhanced liver magnetic resonance imaging in patients at risk for nephrogenic systemic fibrosis.

  2015cites this paper
• Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles

  2015influential citation
• Diagnosing nephrogenic systemic fibrosis in the post‐FDA restriction era

  2015cites this paper
• Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?

  2015cites this paper
• Dose Reduction in Contrast-Enhanced Cervical MR Angiography: Field Strength Dependency of Vascular Signal Intensity, Contrast Administration, and Arteriographic Quality.

  2015cites this paper
• High-Permittivity Thin Dielectric Padding Improves Fresh Blood Imaging of Femoral Arteries at 3 T

  2015cites this paper
• An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis

  2015cites this paper